Media Centre
Latest press releases
-
Fasenra approved in China for the treatment of severe eosinophilic asthma
-
Imfinzi approved in the US for the treatment of resectable non-small cell lung cancer before and after surgery
-
Imfinzi granted Priority Review and Breakthrough Therapy Designation for patients with limited-stage small cell lung cancer in the US
-
Lynparza and Imfinzi combination approved in the EU for patients with mismatch repair proficient advanced or recurrent endometrial cancer
-
Enhertu approved in China for patients with previously treated HER2-positive advanced or metastatic gastric cancer
Medical Releases
These press releases are specifically for health specialist/medical media and are not for consumer press.
